Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could umbilical cord stem cells help kids with cerebral palsy?

NCT ID NCT04314687

Disease control Sponsor: PT. Prodia Stem Cell Indonesia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether stem cells from donated umbilical cords can improve movement and thinking in children with cerebral palsy. 78 children aged 6 months to 3 years will receive either stem cells plus a special liquid (conditioned medium), stem cells alone, or standard therapy. The goal is to see if the combination leads to better motor and cognitive function.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
umbilical cord mesenchymal stem cells and conditioned medium
What this could lead to
If it works, this could point toward a treatment that improves movement and thinking skills in children with cerebral palsy.
What could go wrong
This is an early-phase trial with only 78 children, so results may not apply to everyone. Stem cell therapies can have risks like infection or immune reactions, and the benefits are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1/2

Runs two stages together: safety and dose first, then whether the treatment works.

Participants

About 78 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2021

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 months to 3 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed as Cerebral palsy with total body involvement type * Age between 6 month - 3 years old * Parents requesting for cell therapy * The parents give sign in informed consent form do to examination, therapy, blood sampling collection and observation for their child Exclusion Criteria: * Head circumference less than -3 SD (more than 3 cm) Nellhaus standard * Have diagnosed meningitis and encephalitis * Have diagnosed congenital infection i.e. toxoplasmosis, rubella congenital, cytomegalovirus * Have diagnosed metabolic disorder, chromosome disorder, congenital malformation or neuroregeneratif disease * Progressive disorder * Regressive development disorder * Severe anatomical abnormalities in Brain MRI

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral palsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cerebral palsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cerebral palsy

Contacts and locations

Locations

  • Indonesian National Brain Center

    Jakarta, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.